Dear colleague, 

We invite you to participate in a very interesting survey to improve our understanding of severe cutaneous adverse reactions. While the diagnostic tools and management options for delayed drug reactions have been described in several international guidelines, the clinical practice can vary from one center to another. There is a need to standardize practice to improve patient care.

 The survey linked below should take no more than 10 minutes to complete. https://portal.rimuhc.ca/cim/redcap/surveys/?s=3YJDFAT4AYEYC93A  @GRASS_Survey

 Your name and responses will remain anonymous.
Thank you in advance for participating. Your expertise and time are greatly appreciated.

Ana Copaescu MD FRCPC
Assistant Professor, Division of Adult Allergy and Clinical 
Immunology, Department of Medicine, Montréal General Hospital, McGill University Health Centre (MUHC)
                                          
Moshe Ben-Shoshan MD MSc FRCPC
Associate Professor, Division of Pediatric Allergy and Clinical 
Immunology, Department of Medicine, McGill University Health Centre

Elena Netchiporouk MD MSc FRCPC
Assistant Professor, Director of UGME in Dermatology
Division of Dermatology, McGill University Health Centre

Jonny Peter MB ChB MMed FCP (SA) PhD
Associate Professor, Division of Allergology and Clinical Immunology
Groote Schuur Hospital, University of Cape Town, Cape Town South Africa

 Elizabeth Phillips MD FRCPC FRACP John A. Oates Chair in Clinical Research
Professor of Medicine, Pharmacology, Pathology, Immunology and MicrobiologyVanderbilt University, Nashville, United States

Jason Trubiano BBiomedSci MBBS (hons) FRACP PhD
Associate Professor, Division of Infectious Diseases
Austin Health Hospital, Melbourne, Australia